Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway
Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway
复制标题
Sema4C 通过 p38 MAPK 途径参与体内和体外的肌原性分化。
DOI:
10.1016/j.ejcb.2007.03.002
复制
发表时间:
2007-06-01
影响因子:
6.6
通讯作者:
Fan, Ming
中科院分区:
文献类型:
--
作者:
Wu, Haitao;Wang, Xuan;Fan, Ming
Serna4C is a member of transmembrane sernaphorin proteins which regulate axonal guidance in the developing nervous system. The expression of Sema4C was dramatically induced not only during differentiation of C2Cl2 mouse myoblasts, but also during injury-induced skeletal muscle regeneration. C2Cl2 cells stably or transiently expressing Sema4C both showed increased myogenic differentiation reflected by accelerated myotube formation and expression of muscle-specific proteins. Overexpression of Sema4C elicited p38 phosphorylation directly, and the effects of Sema4C during myogenic differentiation could be abolished by the p38 alpha-specific inhibitor SB203580. Knockdown of Sema4C by siRNA transfection during C2Cl2 myoblasts differentiation could suppress the phosphorylation of p38 followed by dramatically diminished myotube formation. Serna4C could activate the myogenin promoter during myogenic differentiation. This activation could be abolished by p38 inhibitor SB203580. Taken together, these observations reveal novel functional potentialities of Sema4C which suggest that Sema4C promotes terminal myogenic differentiation in a p38 MAPK-dependent manner. (c) 2007 Elsevier GmbH. All rights reserved.